메뉴 건너뛰기




Volumn 24, Issue 6, 2007, Pages 635-642

Comparison of insulin detemir and insulin glargine in subjects with type 1 diabetes using intensive insulin therapy

Author keywords

HbA1c; Hypoglycaemia; Insulin detemir; Insulin glargine; Type 1 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN ASPART; INSULIN DETEMIR; INSULIN GLARGINE;

EID: 34249297061     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2007.02113.x     Document Type: Article
Times cited : (120)

References (35)
  • 1
    • 0027370108 scopus 로고
    • The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
    • Diabetes-Control ACTRG.
    • Diabetes-Control ACTRG. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New Engl J Med 1993 329:977 986.
    • (1993) New Engl J Med , vol.329 , pp. 977-986
  • 2
    • 0032511583 scopus 로고    scopus 로고
    • Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
    • UK Prospective Diabetes Study (UKPDS) Group.
    • UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998 352:837 853.
    • (1998) Lancet , vol.352 , pp. 837-853
  • 3
    • 0031975069 scopus 로고    scopus 로고
    • The effects of improved glycemic control on complications in type 2 diabetes
    • Gaster B, Hirsch IB. The effects of improved glycemic control on complications in type 2 diabetes. Arch Intern Med 1998 158:134 140.
    • (1998) Arch Intern Med , vol.158 , pp. 134-140
    • Gaster, B.1    Hirsch, I.B.2
  • 4
    • 0029147687 scopus 로고
    • Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized prospective 6-year study
    • Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995 28:103 117.
    • (1995) Diabetes Res Clin Pract , vol.28 , pp. 103-117
    • Ohkubo, Y.1    Kishikawa, H.2    Araki, E.3    Miyata, T.4    Isami, S.5    Motoyoshi, S.6
  • 5
    • 0027275397 scopus 로고
    • The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus
    • Reichard P, Nilsson BY, Rosenqvist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. New Engl J Med 1993 329:304 309.
    • (1993) New Engl J Med , vol.329 , pp. 304-309
    • Reichard, P.1    Nilsson, B.Y.2    Rosenqvist, U.3
  • 6
    • 0033530471 scopus 로고    scopus 로고
    • Inadequate suspension of neutral protamine Hagendorn (NPH) insulin in pens
    • Jehle PM, Micheler C, Jehle DR, Breitig D, Boehm BO. Inadequate suspension of neutral protamine Hagendorn (NPH) insulin in pens. Lancet 1999 354:1604 1607.
    • (1999) Lancet , vol.354 , pp. 1604-1607
    • Jehle, P.M.1    Micheler, C.2    Jehle, D.R.3    Breitig, D.4    Boehm, B.O.5
  • 7
    • 0020624323 scopus 로고
    • Clinical factors influencing the absorption of 125I-NPH insulin in diabetic patients
    • Kølendorf K, Bojsen J, Deckert T. Clinical factors influencing the absorption of 125I-NPH insulin in diabetic patients. Horm Metab Res 1983 15:274 278.
    • (1983) Horm Metab Res , vol.15 , pp. 274-278
    • Kølendorf, K.1    Bojsen, J.2    Deckert, T.3
  • 8
    • 0029619489 scopus 로고
    • Albumin binding of insulins acylated with fatty acids: Characterization of the ligand-protein interaction and correlation between binding affinity and timing of the insulin effect in vivo
    • Kurtzhals P, Havelund S, Jonassen I, Kiehr B, Larsen UD, Ribel U, et al. Albumin binding of insulins acylated with fatty acids: characterization of the ligand-protein interaction and correlation between binding affinity and timing of the insulin effect in vivo. Biochem J 1995 312:725 731.
    • (1995) Biochem J , vol.312 , pp. 725-731
    • Kurtzhals, P.1    Havelund, S.2    Jonassen, I.3    Kiehr, B.4    Larsen, U.D.5    Ribel, U.6
  • 9
    • 4344701890 scopus 로고    scopus 로고
    • The mechanism of protraction of insulin detemir, a long-acting, acylated analog of human insulin
    • Havelund S, Plum A, Ribel U, Jonassen I, Volund A, Markussen J, et al. The mechanism of protraction of insulin detemir, a long-acting, acylated analog of human insulin. Pharm Res 2004 21:1498 1504.
    • (2004) Pharm Res , vol.21 , pp. 1498-1504
    • Havelund, S.1    Plum, A.2    Ribel, U.3    Jonassen, I.4    Volund, A.5    Markussen, J.6
  • 10
    • 0038383535 scopus 로고    scopus 로고
    • Insulin glargine: A systematic review of a long-acting insulin analogue
    • Wang F, Carabino JM, Vergara CM. Insulin glargine: a systematic review of a long-acting insulin analogue. Clin Ther 2003 25:1541 1577.
    • (2003) Clin Ther , vol.25 , pp. 1541-1577
    • Wang, F.1    Carabino, J.M.2    Vergara, C.M.3
  • 11
    • 20944432717 scopus 로고    scopus 로고
    • A double-blind, randomized, dose-response study investigating the pharmacodynamic and pharmacokinetic properties of the long-acting insulin analog detemir
    • Plank J, Bodenlenz M, Sinner F, Magnes C, Görzer E, Regittnig W, et al. A double-blind, randomized, dose-response study investigating the pharmacodynamic and pharmacokinetic properties of the long-acting insulin analog detemir. Diabetes Care 2005 28:1107 1112.
    • (2005) Diabetes Care , vol.28 , pp. 1107-1112
    • Plank, J.1    Bodenlenz, M.2    Sinner, F.3    Magnes, C.4    Görzer, E.5    Regittnig, W.6
  • 12
    • 0034117810 scopus 로고    scopus 로고
    • Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo
    • Heinemann L, Linkeschova R, Rave K, Hompesch B, Sedlak M, Heise T. Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo. Diabetes Care 2000 23:644 649.
    • (2000) Diabetes Care , vol.23 , pp. 644-649
    • Heinemann, L.1    Linkeschova, R.2    Rave, K.3    Hompesch, B.4    Sedlak, M.5    Heise, T.6
  • 13
    • 12744274867 scopus 로고    scopus 로고
    • Insulin detemir used in basal-bolus therapy in people with type 1 diabetes is associated with a lower risk of nocturnal hypoglycaemia and less weight gain over 12 months in comparison to NPH insulin
    • De Leeuw I, Vague P, Selam JL, Skeie S, Lang H, Draeger F, et al. Insulin detemir used in basal-bolus therapy in people with type 1 diabetes is associated with a lower risk of nocturnal hypoglycaemia and less weight gain over 12 months in comparison to NPH insulin. Diabetes Obes Metab 2005 7:73 82.
    • (2005) Diabetes Obes Metab , vol.7 , pp. 73-82
    • De Leeuw, I.1    Vague, P.2    Selam, J.L.3    Skeie, S.4    Lang, H.5    Draeger, F.6
  • 14
    • 0343851573 scopus 로고    scopus 로고
    • Efficacy and safety of HOE 901 versus NPH insulin in patients with type 1 diabetes. the European Study Group of HOE 901 in type 1 diabetes
    • Pieber TR, Eugène-Jolchine I, Derobert E. Efficacy and safety of HOE 901 versus NPH insulin in patients with type 1 diabetes. The European Study Group of HOE 901 in type 1 diabetes. Diabetes Care 2000 23:157 162.
    • (2000) Diabetes Care , vol.23 , pp. 157-162
    • Pieber, T.R.1    Eugène-Jolchine, I.2    Derobert, E.3
  • 15
    • 0035146436 scopus 로고    scopus 로고
    • Comparison of the soluble basal insulin analog insulin detemir with NPH insulin: A randomized open crossover trial in type 1 diabetic subjects on basal-bolus therapy
    • Hermansen K, Madsbad S, Perrild H, Kristensen A, Axelsen M. Comparison of the soluble basal insulin analog insulin detemir with NPH insulin: a randomized open crossover trial in type 1 diabetic subjects on basal-bolus therapy. Diabetes Care 2001 24:296 301.
    • (2001) Diabetes Care , vol.24 , pp. 296-301
    • Hermansen, K.1    Madsbad, S.2    Perrild, H.3    Kristensen, A.4    Axelsen, M.5
  • 16
    • 2342621441 scopus 로고    scopus 로고
    • Insulin detemir offers improved glycemic control compared with NPH insulin in people with type 1 diabetes: A randomized clinical trial
    • Home P, Bartley P, Russell-Jones D, Hanaire-Broutin H, Heeg JE, Abrams P, et al. Insulin detemir offers improved glycemic control compared with NPH insulin in people with type 1 diabetes: a randomized clinical trial. Diabetes Care 2004 27:1081 1087.
    • (2004) Diabetes Care , vol.27 , pp. 1081-1087
    • Home, P.1    Bartley, P.2    Russell-Jones, D.3    Hanaire-Broutin, H.4    Heeg, J.E.5    Abrams, P.6
  • 17
    • 2942574527 scopus 로고    scopus 로고
    • Effects of QD insulin detemir or neutral protamine Hagedorn on blood glucose control in patients with type I diabetes mellitus using a basal-bolus regimen
    • Russell-Jones D, Simpson R, Hylleberg B, Draeger E, Bolinder J. Effects of QD insulin detemir or neutral protamine Hagedorn on blood glucose control in patients with type I diabetes mellitus using a basal-bolus regimen. Clin Ther 2004 26:724 736.
    • (2004) Clin Ther , vol.26 , pp. 724-736
    • Russell-Jones, D.1    Simpson, R.2    Hylleberg, B.3    Draeger, E.4    Bolinder, J.5
  • 18
    • 0038418746 scopus 로고    scopus 로고
    • Insulin detemir is associated with more predictable glycemic control and reduced risk of hypoglycemia than NPH insulin in patients with type 1 diabetes on a basal-bolus regimen with premeal insulin aspart
    • Vague P, Selam JL, Skeie S, De Leeuw I, Elte JW, Haahr H, et al. Insulin detemir is associated with more predictable glycemic control and reduced risk of hypoglycemia than NPH insulin in patients with type 1 diabetes on a basal-bolus regimen with premeal insulin aspart. Diabetes Care 2003 26:590 596.
    • (2003) Diabetes Care , vol.26 , pp. 590-596
    • Vague, P.1    Selam, J.L.2    Skeie, S.3    De Leeuw, I.4    Elte, J.W.5    Haahr, H.6
  • 19
    • 21744451635 scopus 로고    scopus 로고
    • Comparison of three multiple injection regimens for Type 1 diabetes: Morning plus dinner or bedtime administration of insulin detemir vs. morning plus bedtime NPH insulin
    • Pieber TR, Draeger E, Kristensen A, Grill V. Comparison of three multiple injection regimens for Type 1 diabetes: morning plus dinner or bedtime administration of insulin detemir vs. morning plus bedtime NPH insulin. Diabet Med 2005 22:850 857.
    • (2005) Diabet Med , vol.22 , pp. 850-857
    • Pieber, T.R.1    Draeger, E.2    Kristensen, A.3    Grill, V.4
  • 20
    • 6044261447 scopus 로고    scopus 로고
    • The 12-month efficacy and safety of insulin detemir and NPH insulin in basal-bolus therapy for the treatment of type 1 diabetes
    • Standl E, Lang H, Roberts A. The 12-month efficacy and safety of insulin detemir and NPH insulin in basal-bolus therapy for the treatment of type 1 diabetes. Diabetes Technol Ther 2004 6:579 588.
    • (2004) Diabetes Technol Ther , vol.6 , pp. 579-588
    • Standl, E.1    Lang, H.2    Roberts, A.3
  • 21
    • 2542576404 scopus 로고    scopus 로고
    • Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes
    • Heise T, Nosek L, Rønn BB, Endahl L, Heinemann L, Kapitza C, et al. Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes. Diabetes 2004 53:1614 1620.
    • (2004) Diabetes , vol.53 , pp. 1614-1620
    • Heise, T.1    Nosek, L.2    Rønn, B.B.3    Endahl, L.4    Heinemann, L.5    Kapitza, C.6
  • 22
    • 0034033028 scopus 로고    scopus 로고
    • Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 Diabetes
    • Ratner RE, Hirsch IB, Neifing JL, Garg SK, Mecca TE, Wilson CA. Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 Diabetes. Diabetes Care 2000 23:639 643.
    • (2000) Diabetes Care , vol.23 , pp. 639-643
    • Ratner, R.E.1    Hirsch, I.B.2    Neifing, J.L.3    Garg, S.K.4    Mecca, T.E.5    Wilson, C.A.6
  • 23
    • 0033865137 scopus 로고    scopus 로고
    • Basal insulin glargine (HOE 901) versus NPH insulin in patients with type 1 diabetes on multiple daily insulin regimens. U.S. Insulin Glargine (HOE 901) Type 1 Diabetes Investigator Group
    • Rosenstock J, Park G, Zimmerman J, Insulin G. Basal insulin glargine (HOE 901) versus NPH insulin in patients with type 1 diabetes on multiple daily insulin regimens. U.S. Insulin Glargine (HOE 901) Type 1 Diabetes Investigator Group. Diabetes Care 2000 23:1137 1142.
    • (2000) Diabetes Care , vol.23 , pp. 1137-1142
    • Rosenstock, J.1    Park, G.2    Zimmerman, J.3    Insulin, G.4
  • 24
    • 0038248890 scopus 로고    scopus 로고
    • Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting insulin analog at mealtime: A 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime
    • Rossetti P, Pampanelli S, Fanelli C, Porcellati F, Costa E, Torlone E, et al. Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime. Diabetes Care 2003 26:1490 1496.
    • (2003) Diabetes Care , vol.26 , pp. 1490-1496
    • Rossetti, P.1    Pampanelli, S.2    Fanelli, C.3    Porcellati, F.4    Costa, E.5    Torlone, E.6
  • 25
    • 34249305791 scopus 로고    scopus 로고
    • Lantus European Public Assessment Report. Available at. Last accessed September 2006.
    • Lantus European Public Assessment Report. Available at http://wwwemeaeuint/humandocs/Humans/EPAR/lantus/lantushtm 2005. Last accessed September 2006.
    • (2005)
  • 27
    • 2442678007 scopus 로고    scopus 로고
    • Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with type 1 diabetes
    • Hermansen K, Fontaine P, Kukolja KK, Peterkova V, Leth G, Gall MA. Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with type 1 diabetes. Diabetologia 2004 47:622 629.
    • (2004) Diabetologia , vol.47 , pp. 622-629
    • Hermansen, K.1    Fontaine, P.2    Kukolja, K.K.3    Peterkova, V.4    Leth, G.5    Gall, M.A.6
  • 28
    • 0003187466 scopus 로고    scopus 로고
    • Standards of medical care for patients with diabetes mellitus
    • American Diabetes Association.
    • American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 2003 26:S33 S50.
    • (2003) Diabetes Care , vol.26
  • 29
    • 0842311525 scopus 로고    scopus 로고
    • Efficacy of conversion from bedtime NPH insulin injection to once- or twice-daily injections of insulin glargine in type 1 diabetic patients using basal/bolus therapy
    • Albright ES, Desmond R, Bell DSH. Efficacy of conversion from bedtime NPH insulin injection to once- or twice-daily injections of insulin glargine in type 1 diabetic patients using basal/bolus therapy. Diabetes Care 2004 27:632 633.
    • (2004) Diabetes Care , vol.27 , pp. 632-633
    • Albright, E.S.1    Desmond, R.2    Bell, D.S.H.3
  • 30
    • 4444307704 scopus 로고    scopus 로고
    • Improved glycemic control without an increase in severe hypoglycemic episodes in intensively treated patients with type I diabetes receiving morning, evening, or split dose insulin glargine
    • Garg SK, Gottlieb PA, Hisatomi ME, D'Souza A, Walker AJ, Izuora KE, et al. Improved glycemic control without an increase in severe hypoglycemic episodes in intensively treated patients with type I diabetes receiving morning, evening, or split dose insulin glargine. Diabetes Res Clin Pract 2004 66:49 56.
    • (2004) Diabetes Res Clin Pract , vol.66 , pp. 49-56
    • Garg, S.K.1    Gottlieb, P.A.2    Hisatomi, M.E.3    D'Souza, A.4    Walker, A.J.5    Izuora, K.E.6
  • 31
    • 8144228075 scopus 로고    scopus 로고
    • Better long-term glycaemic control with the basal insulin glargine as compared with NPH in patients with Type 1 diabetes mellitus given meal-time lispro insulin
    • Porcellati F, Rossetti P, Pampanelli S, Fanelli CG, Torlone E, Scionti L, et al. Better long-term glycaemic control with the basal insulin glargine as compared with NPH in patients with Type 1 diabetes mellitus given meal-time lispro insulin. Diabet Med 2004 21:1213 1220.
    • (2004) Diabet Med , vol.21 , pp. 1213-1220
    • Porcellati, F.1    Rossetti, P.2    Pampanelli, S.3    Fanelli, C.G.4    Torlone, E.5    Scionti, L.6
  • 32
    • 33645054809 scopus 로고    scopus 로고
    • Improved glycaemic control with insulin glargine plus insulin lispro: A multicentre, randomized, cross-over trial in people with Type 1 diabetes
    • Ashwell SG, Amiel SA, Bilous RW, Dashora U, Heller SR, Hepburn DA, et al. Improved glycaemic control with insulin glargine plus insulin lispro: a multicentre, randomized, cross-over trial in people with Type 1 diabetes. Diabet Med 2006 23:285 292.
    • (2006) Diabet Med , vol.23 , pp. 285-292
    • Ashwell, S.G.1    Amiel, S.A.2    Bilous, R.W.3    Dashora, U.4    Heller, S.R.5    Hepburn, D.A.6
  • 33
    • 33748555885 scopus 로고    scopus 로고
    • Insulin detemir lowers the risk of hypoglycaemia and provides more consistent plasma glucose levels compared with NPH insulin in Type 1 diabetes
    • Kølendorf K, Ross GP, Pavlic-Renar I, Perriello G, Philotheou A, Jendle J, et al. Insulin detemir lowers the risk of hypoglycaemia and provides more consistent plasma glucose levels compared with NPH insulin in Type 1 diabetes. Diabet Med 2006 23:729 735.
    • (2006) Diabet Med , vol.23 , pp. 729-735
    • Kølendorf, K.1    Ross, G.P.2    Pavlic-Renar, I.3    Perriello, G.4    Philotheou, A.5    Jendle, J.6
  • 34
    • 6944244979 scopus 로고    scopus 로고
    • Insulin detemir and insulin aspart: A promising basal-bolus regimen for type 2 diabetes
    • Raslova K, Bogoev M, Raz I, Leth G, Gall MA, Hancu N. Insulin detemir and insulin aspart: a promising basal-bolus regimen for type 2 diabetes. Diabetes Res Clin Pract 2004 66:193 201.
    • (2004) Diabetes Res Clin Pract , vol.66 , pp. 193-201
    • Raslova, K.1    Bogoev, M.2    Raz, I.3    Leth, G.4    Gall, M.A.5    Hancu, N.6
  • 35
    • 0028648289 scopus 로고
    • Hypoglycaemia, the most feared complication of insulin therapy
    • McCrimmon RJ, Frier BM. Hypoglycaemia, the most feared complication of insulin therapy. Diabetes Metab 1994 20:503 512.
    • (1994) Diabetes Metab , vol.20 , pp. 503-512
    • McCrimmon, R.J.1    Frier, B.M.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.